Celltrion Inc Is A South Korea Based Biopharmaceutical Company That Specializes In Biosimilars And Novel Biologicsheadquartered In Incheonit Operates Globally With Subsidiaries In The Ukusrussiaand Other Regionsthe Company Was Founded With A Focus On Monoclonal Antibody Therapies And Has Become A Significant Player In The Global Biologics Marketachieving Over Krw 1 Trillion In Annual Sales By 2020 Celltrion Is Known For Pioneering The Worldae S First Antibody Biosimilarproviding Treatments For Autoimmune Diseases And Cancersits Product Pipeline Includes Monoclonal Antibody Biosimilars For Colorectal Cancer And Respiratory Diseasesas Well As Novel Biologics And Vaccines Targeting Hepatitis Binfluenzaand Rabiesadditionallythe Company Offers Contract Manufacturing Services Using Proprietary Mammalian Cell Culture Technologycelltrion Aims To Advance Affordable And Accessible Therapiesensuring That No Patients Are Left Untreated While Expanding Treatment Options Globally Through Innovation
